Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.40 +0.05 (+3.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Transcode Therapeutics (RNAZ) Current Leases (2023 - 2024)

Updated

Analysis

Transcode Therapeutics (RNAZ) Current Leases (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Transcode Therapeutics 1.37 Mn -40.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 38,291.00
Sep 30, 2024 152,481.00
Jun 30, 2024 227,246.00
Mar 31, 2024 339,408.00
Dec 31, 2023 412,280.00
Sep 30, 2023 404,928.00
Jun 30, 2023 397,641.00
Mar 31, 2023 390,419.00
API Access

Transcode Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=RNAZ&period=max&api_key=YOUR_API_KEY